1 “...This report aims to review the evidence and clinical guidance regarding the use of low-carbohydrate...”

2 “...This report aims to review the evidence and clinical guidance regarding the use of low-carbohydrate...”

3 “... low-dose computed tomography (LDCT). Results with conventional radiography and sputum cytology have...”

4 “... low-dose computed tomography (LDCT). Results with conventional radiography and sputum cytology have...”

5 Subjects: “...Low Back Pain / surgery...”

6 Subjects: “...Low Back Pain / therapy...”

7 Subjects: “...Heparin, Low-Molecular-Weight / administration & dosage...”

8 Subjects: “...Heparin, Low-Molecular-Weight / therapeutic use...”

9 Subjects: “...Heparin, Low-Molecular-Weight / therapeutic use...”

10 “... of ticagrelor 60 mg and 90 mg tablets co-administered with low-dose (75 mg to 150 mg) acetylsalicylic acid...”

11 “... of ticagrelor 60 mg and 90 mg tablets co-administered with low-dose (75 mg to 150 mg) acetylsalicylic acid...”

12 “... shorter for those patients who lose weight prior to starting cancer treatment. Maintaining a healthy diet...”

13 “... shorter for those patients who lose weight prior to starting cancer treatment. Maintaining a healthy diet...”

14 “... illness phases. Many patients enter treatment with weight loss and up to 80% lose additional weight during...”

15 “... illness phases. Many patients enter treatment with weight loss and up to 80% lose additional weight during...”

16

17 “.... Rituximab was given a positive recommendation, however the Committee noted that the evidence for repeated...”

18 “.... Rituximab was given a positive recommendation, however the Committee noted that the evidence for repeated...”

19 “... is ongoing about the optimal duration of DAPT. Of note, patient characteristics may be an important factor...”

20 “... is ongoing about the optimal duration of DAPT. Of note, patient characteristics may be an important factor...”